Professor, Medicine, University of Toledo College of Medicine
Hematology
Dr. Roland T. Skeel, MD
|
|
Give Review
Roland Skeel works in the field of Hematology. He studied medicine at University of Cincinnati College of Medicine. He over the years received 1 awards: "Meaningful Use Stage 1 Certification". Roland Skeel is also published. He has 26 publications published. The lastest publication: "Pseudomyxoma peritonei: Sudden cardiac death complicating post operative intraperitoneal treatment with 5-fluorouracil.' Roland T. Skeel accepts Medicare.
Publications
- Defining higher order dimensions of self-reported health: further evidence for a two-dimensional structure.
- A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile Carcinoma: an Eastern Cooperative Oncology Group study (E3893).
- Oncologists'' use of quality of life information: results of a survey of Eastern Cooperative Oncology Group physicians.
- N-Methylformamide in advanced squamous Cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.
- Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast Cancer: an Eastern Cooperative Oncology Group study (PA 185).
- Pseudomyxoma peritonei: Sudden cardiac death complicating post operative intraperitoneal treatment with 5-fluorouracil.
- Conventional dose melphalan is inactive in metastatic melanoma: results of an Eastern Cooperative Oncology Group Study (E1687).
- Quality of life in advanced prostate Cancer: results of a randomized therapeutic trial.
- Fundamental dilemmas of the randomized clinical trial process: results of a survey of the 1,737 Eastern Cooperative Oncology Group investigators.
- Ancrod infusion for antiCoagulation during and after PTCA in a patient with heparin-induced thrombocytopenia.
- Alpha interferon, leucovorin, and 5-fluorouracil (ALF) in advanced Cancer: results of a dose-finding study and evidence of activity in non-small cell lung Cancer.
- Quality of life dimensions that are most important to Cancer patients.
- A description of humanist scholars functioning as ethicists in the clinical setting.
- Radiation therapy and 5-fluorouracil modulated by leucovorin for adenoCarcinoma of the pancreas. A phase I study.
- Justification for evaluating new antiCancer drugs in selected untreated patients with extensive-stage small-cell lung Cancer: an Eastern Cooperative Oncology Group ran...
- Concomitant radiation therapy and constant infusion FUdR for unresectable hepatic metastases.
- Magnetic resonance imaging of hepatic adenoma.
- A phase II study of carboplatin and CHIP in patients with metastatic colon Carcinoma.
- Combination chemotherapy of advanced breast Cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine,...
- Role of scintigraphy in establishing optimal perfusion in hepatic arterial infusion pump chemotherapy.
- Phase II clinical trial of acivicin in advanced breast Cancer: an Eastern Cooperative Oncology Group Study.
- A phase II study of bisantrene in advanced refractory breast Cancer. An Eastern Cooperative Oncology Group pilot study.
- Phase II trials of Baker's antifol, bleomycin, CCNU, streptozotocin, tilorone, and 5-fluorodeoxyuridine plus arabinosyl cytosine in metastatic breast Cancer.
- Results of a phase II protocol for evaluation of new chemotherapeutic regimens in patients with inoperable non-small Cell lung carcinoma (EST-2575, generation I).
- Prognostic effect of weight loss prior to chemotherapy in Cancer patients. Eastern Cooperative Oncology Group.
Schools
University Of Cincinnati College Of Medicine
Henry Ford Hospital
National Institute Health
Yale
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Henry Ford Hospital - Wayne State University -
University of Cincinnati College of Medicine
Hospital
-
Mercy St. Vincent Medical Center
Drug Facts
| NPI NUMBER | 1346246139 | |
| NPPES Provider LastName | SKEEL | |
| NPPES Provider FirstName | ROLAND | |
| NPPES Provider ZIPCode | 436145811 | |
| NPPES Provider State | OH | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1049.0 | |
| Distinct Opioid Count | 8.0 | |
| Opioid Claim Count | 333.0 | |
| Percent Opioid Claims | 31.74 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346246139 |
| Last Name Of The Provider | SKEEL |
| First Name Of The Provider | ROLAND |
| View All |
Similar Doctors
|
|
Dr. Timothy C. Kasunic, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iman Mohamed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Howard L. Ritter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bahu S. Shaikh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cecilia Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert L. Booth Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew J. Britton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas E. Downs, MD |
|
|
Dr. Paul L. Schaefer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary R. Smith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ira Surolia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cherian Verghese, MD |